Text Size
781 studies found for:    Open Studies | "Carcinoma, Bronchogenic"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
21 Not yet recruiting Docetaxel With or Without FGFR Inhibitor AZD4547 in Treating Patients With Recurrent Non-Small Cell Lung Cancer
Conditions: Recurrent Non-small Cell Lung Cancer;   Squamous Cell Lung Cancer
Interventions: Drug: docetaxel;   Drug: FGFR inhibitor AZD4547;   Other: laboratory biomarker analysis;   Other: pharmacological study
22 Recruiting Carinal Biopsy Study
Condition: Non-small Cell Lung Cancer
Interventions: Procedure: Biopsy of the major carinal area;   Procedure: Biopsy of abnormal & suspicious areas of the bronchial tree;   Procedure: Evaluation of the tumor for DNA mutations;   Procedure: Bronchoalveolar Lavage (BAL) for cytokine analysis;   Procedure: Correlation of flow cytometric & RT PCR for TNM stage;   Procedure: Analysis of lymph nodes
23 Unknown † Detection of EGFR Mutations in the Blood of Patients With Non-Small Cell Lung Cancer: a Feasibility Study
Condition: Non Small Cell Lung Cancer
Intervention:
24 Unknown † Non-Small Cell Lung Cancer and Quality of Life
Condition: Non Small Cell Lung Cancer
Intervention:
25 Not yet recruiting The Effect Of Aspirin On Survival in Lung Cancer
Conditions: Non Small Cell Lung Cancer;   Survival;   Aspirin
Interventions: Drug: Aspirin 75 mg;   Other: no aspirin
26 Unknown † Study of Concurrent Chemo-radiotherapy Combined With Recombinant Human Endostatin for Local Advanced Non-small Cell Lung Cancer (NSCLC)
Condition: Non-small Cell Lung Cancer
Interventions: Radiation: radiotherapy combined with EP;   Drug: radiotherapy / EP combined with recombinant human endostatin
27 Recruiting Study Of Dacomitinib In Advanced NSCLC Patients (Post Chemo Or Select First Line) To Evaluate Prophylactic Intervention On Derm And GI AEs And PRO
Condition: Non Small Cell Lung Cancer (NSCLC)
Interventions: Drug: Dacomitinib Plus Blinded Doxycycline or Placebo;   Drug: Dacomitinib Plus Probiotic Plus Topical Alclometasone cream;   Drug: Dacomitinib
28 Recruiting Study of Nivolumab (BMS-936558) in Combination With Gemcitabine/Cisplatin, Pemetrexed/Cisplatin, Carboplatin/Paclitaxel, Bevacizumab Maintenance, Erlotinib, Ipilimumab or as Monotherapy in First-Line or in Switch Maintenance in Subjects With Stage IIIB/IV Non-small Cell Lung Cancer (NSCLC)
Condition: Non-small Cell Lung Cancer
Interventions: Biological: Nivolumab;   Drug: Gemcitabine;   Drug: Cisplatin;   Drug: Pemetrexed;   Drug: Paclitaxel;   Drug: Carboplatin;   Drug: Bevacizumab;   Drug: Erlotinib;   Biological: Ipilimumab
29 Recruiting Specialized Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
Condition: Lung Cancer
Interventions: Drug: carboplatin;   Drug: paclitaxel;   Radiation: 3-dimensional conformal radiation therapy;   Radiation: hypofractionated radiation therapy;   Radiation: intensity-modulated radiation therapy
30 Recruiting Intercalated Administration of PamCis With Gefitinib or Placebo as First Line Lung Adenocarcinoma in Never Smokers
Conditions: Non Small Cell Lung Cancer;   Adenocarcinoma
Interventions: Drug: Gefitinib;   Drug: Placebo;   Drug: Pemetrexed plusCIsplatin
31 Recruiting Stereotactic Radiosurgery or Other Local Ablation Then Erlotinib in Epidermal Growth Factor Receptor (EGFR)
Condition: Non Small Cell Lung Cancer
Interventions: Procedure: Stereostatic Radiosurgery;   Drug: Erlotinib
32 Recruiting A Non Interventional Study With Doce Onkovis (Docetaxel) Utilized for the Treatment of Cancer
Condition: Carcinoma
Intervention:
33 Recruiting Cisplatin and Gemcitabine With or Without Bevacizumab in EGFR Wild-type Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: cisplatin and gemcitabine combination with Bevacizumab;   Drug: Gemcitabine combined with cisplatin chemotherapy
34 Recruiting PKCi & mTOR Inhibition With Auranofin+Sirolimus for Squamous Cell Lung Cancer
Conditions: Adenosquamous Cell Lung Cancer;   Recurrent Non-small Cell Lung Cancer;   Squamous Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer
Interventions: Drug: sirolimus;   Drug: auranofin
35 Unknown † Safety Study: Combined Modality Treatment for Non-Small Cell Lung Cancer
Condition: Non-Small Cell Lung Cancer
Intervention: Procedure: Extracorporeal Photochemotherapy With Transimmunization
36 Unknown † Pre-operative Chemotherapy Versus Concurrent Chemoradiotherapy in N2 Positive IIIA Non Small Cell Lung Cancer (NSCLC)
Condition: Lung Cancer
Interventions: Drug: chemotherapy;   Drug: Concurrent chemoradiation therapy;   Radiation: Concurrent chemoradiation therapy
37 Not yet recruiting Efficacy and Safety of a Sunscreen Against Porfimer Sodium-induced Phototoxicity to Visible Light
Conditions: High-grade Dysplasia in Barrett Esophagus;   Non Small Cell Lung Cancer;   Esophageal Cancer
Interventions: Drug: Solar Protection Formula SPF® 60;   Procedure: Photobiological testing
38 Recruiting Docetaxel Combined With Cisplatin as First Line in Patients With Metastatic Non-small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer Metastatic
Intervention: Drug: cisplatin, docetaxel
39 Not yet recruiting Docetaxel With or Without Low-dose, Short Course Sunitinib in Refractory Solid Tumors
Conditions: Solid Tumors;   Breast Cancer;   Non-small Cell Lung Cancer;   Prostate Cancer;   Gastric Cancer
Interventions: Drug: Docetaxel;   Drug: Sunitinib
40 Recruiting Risk Adapted SABR(SABR) in Stage I NSCLC And Lung Metastases
Conditions: Carcinoma, Non-Small-Cell Lung;   Neoplasm Metastasis
Interventions: Radiation: 34 Gy in a single fraction;   Radiation: 54Gy 18Gy/fr. x 3 fractions;   Radiation: 50Gy (12 x 5 fr.s);   Radiation: 60Gy (7.5Gy x 8fr.)
To Top

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
† Indicates status has not been verified in more than two years